Stay updated on Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.

Latest updates to the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page
- CheckyesterdayChange DetectedRevision updated to v3.5.0, replacing the previous revision v3.4.3.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedPlatform revision updated from v3.4.2 to v3.4.3; no changes to the study details.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedFooter revision tag updated from v3.4.1 to v3.4.2; the previous revision tag was removed.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedThe glossary is now displayed, QC-related labels have been updated (Last Update Submitted that Met QC Criteria) with the footer text showing No FEAR Act Data, and the site revision is now Revision: v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check66 days agoChange DetectedRevision: v3.3.4 was added, replacing the previous v3.3.3. This is a minor site maintenance update and does not affect study details or other visible content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.